| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Challenges in Using MCDA for Reimbursement Decisions on New Medicines?
|
Walker, Andrew
|
|
2016
|
19 |
2 |
p. 123-124
2 p.
|
artikel
|
| 2 |
Comprehensively Measuring Health-Related Subjective Well-Being: Dimensionality Analysis for Improved Outcome Assessment in Health Economics
|
de Vries, Marieke
|
|
2016
|
19 |
2 |
p. 167-175
9 p.
|
artikel
|
| 3 |
Copyright/Subscription
|
|
|
2016
|
19 |
2 |
p. iii-
1 p.
|
artikel
|
| 4 |
Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness
|
Celano, Christopher M.
|
|
2016
|
19 |
2 |
p. 185-191
7 p.
|
artikel
|
| 5 |
Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia
|
Tilden, Dominic
|
|
2016
|
19 |
2 |
p. 145-152
8 p.
|
artikel
|
| 6 |
Erratum
|
|
|
2016
|
19 |
2 |
p. 296-
1 p.
|
artikel
|
| 7 |
Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?
|
Whyte, Sophie
|
|
2016
|
19 |
2 |
p. 138-144
7 p.
|
artikel
|
| 8 |
Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States
|
Asche, Carl V.
|
|
2016
|
19 |
2 |
p. 239-248
10 p.
|
artikel
|
| 9 |
Examining the Value of Menopausal Symptom Relief Among US Women
|
Craig, Benjamin M.
|
|
2016
|
19 |
2 |
p. 158-166
9 p.
|
artikel
|
| 10 |
Expanding Health Technology Assessments to Include Effects on the Environment
|
Marsh, Kevin
|
|
2016
|
19 |
2 |
p. 249-254
6 p.
|
artikel
|
| 11 |
Improving Adherence to Cardiovascular Therapies: An Economic Evaluation of a Randomized Pragmatic Trial
|
Smith, David H.
|
|
2016
|
19 |
2 |
p. 176-184
9 p.
|
artikel
|
| 12 |
Instructions for Authors
|
|
|
2016
|
19 |
2 |
p. I-II
nvt p.
|
artikel
|
| 13 |
Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection: A Systematic Review
|
Koufopoulou, Maria
|
|
2016
|
19 |
2 |
p. 267-276
10 p.
|
artikel
|
| 14 |
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
|
Marsh, Kevin
|
|
2016
|
19 |
2 |
p. 125-137
13 p.
|
artikel
|
| 15 |
Patient-Centered Outcomes of Medication Adherence Interventions: Systematic Review and Meta-Analysis
|
Conn, Vicki S.
|
|
2016
|
19 |
2 |
p. 277-285
9 p.
|
artikel
|
| 16 |
Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer
|
Gries, Katharine S.
|
|
2016
|
19 |
2 |
p. 218-225
8 p.
|
artikel
|
| 17 |
Responsiveness to Change in PROMIS® Measures among Children with Asthma: A Report from the PROMIS® Pediatric Asthma Study
|
Howell, Carrie R.
|
|
2016
|
19 |
2 |
p. 192-201
10 p.
|
artikel
|
| 18 |
Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review
|
Herdman, Michael
|
|
2016
|
19 |
2 |
p. 255-266
12 p.
|
artikel
|
| 19 |
Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
|
Veldwijk, Jorien
|
|
2016
|
19 |
2 |
p. 202-209
8 p.
|
artikel
|
| 20 |
Systematic Review of Economic Evaluations of Units Dedicated to Acute Coronary Syndromes
|
Azeredo-Da-Silva, André Luis Ferreira
|
|
2016
|
19 |
2 |
p. 286-295
10 p.
|
artikel
|
| 21 |
Table of Contents
|
|
|
2016
|
19 |
2 |
p. i-ii
nvt p.
|
artikel
|
| 22 |
The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index
|
Heijnsdijk, Eveline A.M.
|
|
2016
|
19 |
2 |
p. 153-157
5 p.
|
artikel
|
| 23 |
The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan
|
Hammad, Eman A.
|
|
2016
|
19 |
2 |
p. 233-238
6 p.
|
artikel
|
| 24 |
Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
|
Mulhern, Brendan
|
|
2016
|
19 |
2 |
p. 210-217
8 p.
|
artikel
|
| 25 |
Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales
|
Weernink, Marieke G.M.
|
|
2016
|
19 |
2 |
p. 226-232
7 p.
|
artikel
|
Tijdschrift beschrijving